UPDATE: Stifel Initiates Coverage On HealthStream On Platform In Transition
In a report published Tuesday, Stifel analyst Steve Rubis initiated coverage on HealthStream (NASDAQ: HSTM) with a Hold rating.
In the report, Stifel noted, “We are initiating coverage of HealthStream with a Hold rating on the shares. In our view, HealthStream represents a SaaS-based distribution platform for workforce development and performance improvement solutions focused on healthcare professionals.
"We believe HealthStream's competitive advantage lies in its depth and breadth of content, specifically its portfolio of workforce development solutions aimed at government regulatory requirements and professional designation requirements. Although we believe HealthStream operates a strong SaaS-based distribution platform, we believe the company lacks a proprietary technological competitive advantage.”
HealthStream closed on Monday at $26.15.
Latest Ratings for HSTM
|Jan 2017||First Analysis||Downgrades||Equal-Weight||Underweight|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.